EBS - Latest News
Emergent BioSolutions Inc. (EBS), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NYSE.
Market capitalization stands near $429.8M. Beta to the broader market is 2.33.
The article list below shows the most recent EBS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent EBS Headlines
Hantavirus cases spark surge in pharma and biotech stocks — here's why
cnbc.com - May 11, 2026
Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutio
Emergent BioSolutions Inc. (EBS) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 1, 2026
Emergent BioSolutions Inc.
Emergent BioSolutions Reports First Quarter 2026 Financial Results
globenewswire.com - Apr 30, 2026
GAITHERSBURG, Md. , April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc.
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
globenewswire.com - Apr 30, 2026
GAITHERSBURG, Md. , April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc.
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
globenewswire.com - Apr 29, 2026
GAITHERSBURG, Md. , April 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc.
How News Affects EBS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track EBS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked EBS news questions
- What is the latest EBS news headline?
- The most recent EBS headline (May 11, 2026) is "Hantavirus cases spark surge in pharma and biotech stocks — here's why". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the EBS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What EBS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual EBS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.